Lena M. Schmid

Vienna, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Association of Mitral Annular Disjunction on Magnetic Resonance Imaging With Cardiovascular Outcomes.

Association of Mitral Annular Disjunction on Magnetic Resonance Imaging With Cardiovascular Outcomes.

Journal: European journal of clinical investigation

Published: April 18, 2026

Renal cortical T1 times at 1.5 T: exploratory reference estimates from a real-world cohort with preserved renal function.

Renal cortical T1 times at 1.5 T: exploratory reference estimates from a real-world cohort with preserved renal function.

Journal: European journal of radiology open

Published: February 02, 2026

Fibroblast growth factor 23 is associated with cardiac disease severity in transthyretin amyloid cardiomyopathy.

Fibroblast growth factor 23 is associated with cardiac disease severity in transthyretin amyloid cardiomyopathy.

Journal: Scientific reports

Published: February 02, 2026

Hereditary Transthyretin Amyloidosis in Austria: Clinical, Genetic, and Demographic Insights from a Nationwide Cohort.

Hereditary Transthyretin Amyloidosis in Austria: Clinical, Genetic, and Demographic Insights from a Nationwide Cohort.

Journal: Journal of clinical medicine

Published: January 26, 2026

The Neutrophil-Lymphocyte Ratio Is Associated with Cardiac Magnetic Resonance Imaging-Derived Myocardial Fibrosis.

The Neutrophil-Lymphocyte Ratio Is Associated with Cardiac Magnetic Resonance Imaging-Derived Myocardial Fibrosis.

Journal: Journal of clinical medicine

Published: January 14, 2026

CMR-derived skeletal muscle T1 time and extracellular volume as novel diagnostic markers for cardiac amyloidosis.

CMR-derived skeletal muscle T1 time and extracellular volume as novel diagnostic markers for cardiac amyloidosis.

Journal: European journal of clinical investigation

Published: December 22, 2025

Insights into the renin-angiotensin-aldosterone system in transthyretin amyloid cardiomyopathy.

Insights into the renin-angiotensin-aldosterone system in transthyretin amyloid cardiomyopathy.

Journal: European journal of heart failure

Published: December 01, 2025

Performance on the one-minute sit-to-stand test predicts long-term adverse outcomes in pulmonary hypertension.

Performance on the one-minute sit-to-stand test predicts long-term adverse outcomes in pulmonary hypertension.

Journal: Scientific reports

Published: September 26, 2025

Impact of disease-modifying therapy on [99mTc]Tc-DPD SPECT/CT markers in transthyretin cardiac amyloidosis enabled by artificial intelligence.

Impact of disease-modifying therapy on [99mTc]Tc-DPD SPECT/CT markers in transthyretin cardiac amyloidosis enabled by artificial intelligence.

Journal: European journal of nuclear medicine and molecular imaging

Published: September 05, 2025

Additive diagnostic value of thoracic SPECT/CT imaging in perugini grade 1 patients who underwent bone scintigraphy.

Additive diagnostic value of thoracic SPECT/CT imaging in perugini grade 1 patients who underwent bone scintigraphy.

Journal: European journal of nuclear medicine and molecular imaging

Published: August 13, 2025

Applicability of phase 3 trial selection criteria to real-world transthyretin amyloid cardiomyopathy patients.

Applicability of phase 3 trial selection criteria to real-world transthyretin amyloid cardiomyopathy patients.

Journal: Scientific reports

Published: June 10, 2025

Prevalence of Autonomic Dysfunction and Correlation with Markers of Disease Severity in Cardiac Amyloidosis.

Prevalence of Autonomic Dysfunction and Correlation with Markers of Disease Severity in Cardiac Amyloidosis.

Journal: Journal of clinical medicine

Published: May 26, 2025

Showing 1-12 of 17

Last Updated: 09/26/2026